image
Vaccinex, Inc. VCNX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.16
-15.1 %
$ 8.83 M
Market Cap
-0.8
P/E
CASH FLOW STATEMENT
-17.2 M OPERATING CASH FLOW
9.65%
Growth Rates
1Year 9.65%
3Years 15.58%
5Years 7.37%
7Years 1.91%
10Years 0.00%
-67 K INVESTING CASH FLOW
32.32%
Growth Rates
1Year 32.32%
3Years 38.64%
5Years 65.76%
7Years 29.74%
10Years 0.00%
12.4 M FINANCING CASH FLOW
-26.69%
Growth Rates
1Year -26.69%
3Years -30.30%
5Years -21.20%
7Years -3.83%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Vaccinex, Inc.
image
Net Income -20.3 M
Depreciation & Amortization 119 K
Capital Expenditures -67 K
Stock-Based Compensation 474 K
Change in Working Capital 318 K
Others 2.69 M
Free Cash Flow -17.3 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (20.3) (19.8) (22.4) (28.9) (31.9) (29.5) (18.8) (13.9)
Depreciation & Amortization 0.1 0.2 0.2 0.3 0.2 0.2 0.2 0.2
Deferred Income Tax 0 (0.7) (0.9) 65 K 0 1.9 (3.7) (9.3)
Stock Based Compensation 0.5 0.5 0.5 0.7 0.4 0.2 0.3 0.1
Other Operating Activities 2.1 0.7 0.5 0.3 44 K 0.3 1.2 1.6
Change in Working Capital 0.3 11 K (3.2) (1.1) 0.5 1.6 (0.6) 1.7
Cash From Operations (17.2) (19.1) (25.3) (28.6) (30.7) (25.3) (21.4) (19.7)
INVESTING CASH FLOW
Capital Expenditures 67 K 99 K 32 K (0.3) 78 K (0.2) 68 K (0.8)
Other Items 0 0 0 0 14.2 (14.0) 0 0
Cash From Investing Activities 67 K 99 K 32 K (0.3) 14.1 (14.2) 68 K (0.8)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0
Total Debt Repaid 74 K 75 K (8.5) 9.0 0 (5.5) 4.0 5.7
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 (1.0) (0.7) 0 9.3 20.0 21.4
Cash From Financing Activities 12.4 17.0 23.3 36.8 13.8 41.0 24.0 16.4
CHANGE IN CASH
Net Change In Cash (4.9) (2.2) (2.0) 7.8 (2.8) 1.4 2.5 (4.2)
FREE CASH FLOW
Free Cash Flow (17.3) (19.2) (25.3) (28.9) (30.8) (25.5) (21.5) (20.5)